| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008418674 |
| P356 | DOI | 10.1038/NATURE06663 |
| P3181 | OpenCitations bibliographic resource ID | 1988351 |
| P698 | PubMed publication ID | 18305483 |
| P2093 | author name string | Gourab Bhattacharjee | |
| Hugh Rosen | |||
| Florence Schaffner | |||
| Wolfram Ruf | |||
| Patricia Andrade-Gordon | |||
| Frank Niessen | |||
| Rafal Pawlinski | |||
| Jerold Chun | |||
| Christian Furlan-Freguia | |||
| Claudia K. Derian | |||
| P2860 | cites work | Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response | Q28589548 |
| Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3 | Q28593745 | ||
| An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 | ||
| Taking dendritic cells into medicine | Q29619243 | ||
| Roles of protease-activated receptors in a mouse model of endotoxemia | Q33370039 | ||
| Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. | Q33815424 | ||
| Dendritic-cell trafficking to lymph nodes through lymphatic vessels | Q33989067 | ||
| Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants | Q34303850 | ||
| Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation | Q34380698 | ||
| Steady-state and inflammatory dendritic-cell development | Q34591334 | ||
| The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome | Q35051545 | ||
| Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia. | Q35839848 | ||
| Emerging roles of tissue factor in viral hemorrhagic fever | Q35868726 | ||
| Interactions between the innate immune and blood coagulation systems | Q35885818 | ||
| Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network | Q36184401 | ||
| The P2X7 receptor: a key player in IL-1 processing and release | Q36425273 | ||
| Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo | Q42766632 | ||
| Characterization of the systemic loss of dendritic cells in murine lymph nodes during polymicrobial sepsis | Q43495359 | ||
| CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis | Q44826402 | ||
| Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. | Q45086529 | ||
| A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model | Q46174987 | ||
| Sphingosine-1-phosphate mediates migration of mature dendritic cells. | Q46664090 | ||
| Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues | Q46836256 | ||
| Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation. | Q52578077 | ||
| Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3. | Q53567358 | ||
| Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles | Q61764022 | ||
| A coagulation factor VII deficiency protects against acute inflammatory responses in mice | Q79281558 | ||
| Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response | Q82252356 | ||
| P433 | issue | 7187 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| dendritic cell | Q506253 | ||
| Coagulation factor II | Q14821020 | ||
| Sphingosine kinase 1 | Q14913839 | ||
| Coagulation factor II (thrombin) receptor | Q21987377 | ||
| Sphingosine-1-phosphate receptor 3 | Q21988044 | ||
| P304 | page(s) | 654–658 | |
| P577 | publication date | 2008-04-03 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation | |
| P478 | volume | 452 |
| Q82604453 | Acting together, bacterial clusters initiate coagulation |
| Q33558189 | Activated factor X signaling via protease-activated receptor 2 suppresses pro-inflammatory cytokine production from lipopolysaccharide-stimulated myeloid cells |
| Q37241529 | Activated protein C in sepsis: the promise of nonanticoagulant activated protein C. |
| Q34090836 | Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice. |
| Q34509799 | Adipocyte lipolysis-stimulated interleukin-6 production requires sphingosine kinase 1 activity |
| Q33945064 | An update on the biology of sphingosine 1-phosphate receptors. |
| Q52950237 | Anti-inflammatory effects of activated protein C on human dendritic cells. |
| Q30487082 | Biological roles of lysophospholipid receptors revealed by genetic null mice: an update |
| Q37664468 | Breaking the wall: targeting of the endothelium by pathogenic bacteria |
| Q37859560 | Ca2+ signaling in the regulation of dendritic cell functions |
| Q38204272 | Chemical and genetic tools to explore S1P biology |
| Q35684358 | Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules |
| Q38962343 | Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor-thrombin cross-talk |
| Q91884309 | Coagulopathies and inflammatory diseases: '…glimpse of a Snark' |
| Q64115941 | Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus |
| Q39186343 | Complement in ANCA-associated vasculitis: mechanisms and implications for management |
| Q33381051 | Counteracting clotting in sepsis |
| Q24652518 | Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis |
| Q36628592 | Current trends in inflammatory and immunomodulatory mediators in sepsis |
| Q35219875 | Cytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa-induced lung injury in mice |
| Q38113929 | Danger control programs cause tissue injury and remodeling. |
| Q27000818 | Dangerous liaisons: how the immune system deals with factor VIII |
| Q35782993 | Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria |
| Q42929711 | Defibrotide: a Swiss Army knife intervention in the battle against cerebral malaria |
| Q42717913 | Dendritic Cells in Sepsis: Pathological Alterations and Therapeutic Implications |
| Q30423883 | Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury |
| Q37123314 | Dendritic cell subtypes from lymph nodes and blood show contrasted gene expression programs upon Bluetongue virus infection |
| Q34979529 | Differential gene expression in thrombomodulin (TM; CD141)(+) and TM(-) dendritic cell subsets |
| Q35019936 | Discovery, design and synthesis of a selective S1P(3) receptor allosteric agonist |
| Q37289163 | ETS-1-mediated transcriptional up-regulation of CD44 is required for sphingosine-1-phosphate receptor subtype 3-stimulated chemotaxis |
| Q37350158 | Effects of Aedes aegypti salivary components on dendritic cell and lymphocyte biology. |
| Q37142196 | Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality |
| Q42872080 | Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation |
| Q37918456 | Endothelium--role in regulation of coagulation and inflammation |
| Q30532710 | Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1. |
| Q99711242 | Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic |
| Q37582945 | Evasion of interferon responses by Ebola and Marburg viruses |
| Q51740874 | Exploring the Phe-Gly dipeptide-derived piperazinone scaffold in the search for antagonists of the thrombin receptor PAR1. |
| Q57233402 | Expressed Sequence Tags (ESTs) analysis ofTenebrio molitorlarvae |
| Q93099625 | Expression of sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 in malaria-associated acute lung injury/acute respiratory distress syndrome in a mouse model |
| Q34707273 | Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor-1 and mediates cell signaling and barrier protection |
| Q44760202 | Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells |
| Q33816773 | Functional promoter variants in sphingosine 1-phosphate receptor 3 associate with susceptibility to sepsis-associated acute respiratory distress syndrome |
| Q36096028 | Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of eight studies |
| Q37273299 | Harmful molecular mechanisms in sepsis |
| Q37967187 | Immune regulation by sphingosine 1-phosphate and its receptors |
| Q36837408 | Immunochemical termination of self-tolerance |
| Q28482145 | In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody |
| Q38284033 | Increased survival and reduced neutrophil infiltration of the liver in Rab27a- but not Munc13-4-deficient mice in lipopolysaccharide-induced systemic inflammation. |
| Q38410152 | Inflammatory Function of CX3CR1+ CD8+ T Cells in Treated HIV Infection Is Modulated by Platelet Interactions |
| Q37457072 | Innate immunity, coagulation and placenta-related adverse pregnancy outcomes |
| Q39018377 | Innate immunity, hemostasis and matrix remodeling: PTX3 as a link |
| Q35853199 | Insights into the pharmacological relevance of lysophospholipid receptors |
| Q36190599 | Interface between hemostasis and adaptive immunity |
| Q30429523 | International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature |
| Q54402593 | Involvement of proteinase activated receptor-2 in the vascular response to sphingosine 1-phosphate. |
| Q35242288 | Knock out of S1P3 receptor signaling attenuates inflammation and fibrosis in bleomycin-induced lung injury mice model |
| Q33347810 | Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P1 and S1P3 determine efficiency of chemical probe identification by ultrahigh-throughput screening |
| Q38692356 | Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology. |
| Q33384817 | Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway |
| Q37065724 | Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children |
| Q34025135 | Lysophospholipid receptor nomenclature review: IUPHAR Review 8. |
| Q37173208 | Lysophospholipid receptors in vertebrate development, physiology, and pathology |
| Q26859168 | Lysophospholipids and their receptors in the central nervous system |
| Q33829692 | Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget |
| Q37132869 | Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids |
| Q34458426 | Modulation of Chemokines and Allergic Airway Inflammation by Selective Local Sphingosine-1-phosphate Receptor 1 Agonism in Lungs |
| Q34981539 | Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model |
| Q34429846 | Mycobacterium tuberculosis infection and tissue factor expression in macrophages |
| Q36484486 | Novel selective allosteric and bitopic ligands for the S1P(3) receptor. |
| Q56435439 | Oxidative Stress: A Potential Therapeutic Target in Placental Malaria |
| Q90703154 | Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis |
| Q38129719 | Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond |
| Q51051591 | Perioperative release of pro-regenerative biochemical signals from human renal allografts subjected to ischemia-reperfusion injury. |
| Q45141825 | Protease-activated receptor 1 suppresses Helicobacter pylori gastritis via the inhibition of macrophage cytokine secretion and interferon regulatory factor 5. |
| Q88208247 | Protease-activated receptor signalling by coagulation proteases in endothelial cells |
| Q36166264 | Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects. |
| Q41525556 | Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study |
| Q58836876 | Protease-activated receptor-2 signalling by tissue factor on dendritic cells suppresses antigen-specific CD4+ T-cell priming |
| Q37494702 | Protective mechanisms of activated protein C in severe inflammatory disorders. |
| Q37929004 | Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm |
| Q38894933 | Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC. |
| Q42593720 | Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. |
| Q57302349 | Regulation of Immune Cell Migration by Sphingosine-1-Phosphate |
| Q35551835 | Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors |
| Q37960383 | Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells |
| Q33996371 | Regulation of the protein C anticoagulant and antiinflammatory pathways |
| Q37869814 | Review of cellular and molecular pathways linking thrombosis and innate immune system during sepsis. |
| Q38908690 | Role of thrombin in the pathogenesis of central nervous system inflammatory diseases |
| Q34676688 | Role of tissue factor in thrombosis in antiphospholipid antibody syndrome |
| Q90724393 | Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases |
| Q46315054 | S1PR3 Signaling Drives Bacterial Killing and Is Required for Survival in Bacterial Sepsis. |
| Q38755161 | SPHK1/sphingosine kinase 1-mediated autophagy differs between neurons and SH-SY5Y neuroblastoma cells. |
| Q28741929 | Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior |
| Q43223915 | Severe community acquired pneumonia update: mortality, mechanisms and medical intervention |
| Q33870369 | Signal transduction by protease-activated receptors |
| Q37116968 | Spatial localization of bacteria controls coagulation of human blood by 'quorum acting' |
| Q44965785 | Sphingolipids in the lungs. |
| Q30278837 | Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury |
| Q36636026 | Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways |
| Q47881999 | Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair. |
| Q37909176 | Sphingosine 1-phosphate in coagulation and inflammation. |
| Q37226246 | Sphingosine 1-phosphate receptors are essential mediators of eyelid closure during embryonic development |
| Q28741063 | Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions |
| Q41228347 | Sphingosine kinase 1 inhibition improves lipopolysaccharide/D-galactosamine-induced acute liver failure by inhibiting mitogen-activated protein kinases pathway |
| Q34166226 | Sphingosine kinase 1 mediation of expression of the anaphylatoxin receptor C5L2 dampens the inflammatory response to endotoxin |
| Q37289270 | Sphingosine kinases are not required for inflammatory responses in macrophages |
| Q38869471 | Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation |
| Q26775993 | Sphingosine-1-Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and Inflammation |
| Q34474363 | Sphingosine-1-phosphate and immune regulation: trafficking and beyond |
| Q52789739 | Sphingosine-1-phosphate and its receptors in anti-neutrophil cytoplasmic antibody-associated vasculitis. |
| Q28235893 | Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection |
| Q37241418 | Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. |
| Q38978590 | Sphingosine-1-phosphate induces thrombin receptor PAR-4 expression to enhance cell migration and COX-2 formation in human monocytes. |
| Q34606305 | Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. |
| Q39618723 | Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin |
| Q36539650 | Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury |
| Q38016831 | Sphingosine-1-phosphate signaling in physiology and diseases. |
| Q37173184 | Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling |
| Q35053984 | Streptococcal SpeB cleaved PAR-1 suppresses ERK phosphorylation and blunts thrombin-induced platelet aggregation |
| Q30404361 | Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus |
| Q28084493 | Systemic inflammation in xenograft recipients (SIXR): A new paradigm in pig-to-primate xenotransplantation? |
| Q35085219 | Systemic inflammation in xenograft recipients precedes activation of coagulation |
| Q37804572 | TAM receptor signaling and autoimmune disease |
| Q90642085 | Targeting Sphingosine Kinases for the Treatment of Cancer |
| Q34364844 | Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond |
| Q30457536 | Tempol, an intracellular antioxidant, inhibits tissue factor expression, attenuates dendritic cell function, and is partially protective in a murine model of cerebral malaria. |
| Q40540246 | Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles. |
| Q38688341 | The Angiopoietin-Tie2 Signaling Axis in Systemic Inflammation |
| Q26748848 | The SphKs/S1P/S1PR1 axis in immunity and cancer: more ore to be mined |
| Q37010807 | The alliance of sphingosine-1-phosphate and its receptors in immunity |
| Q89625555 | The differences in brain stem transcriptional profiling in hypertensive ISIAH and normotensive WAG rats |
| Q37942050 | The endothelial cell protein C receptor: cell surface conductor of cytoprotective coagulation factor signaling. |
| Q34486205 | The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation |
| Q33711050 | The many faces of tissue factor |
| Q35064492 | The occupancy of endothelial protein C receptor by its ligand modulates the par-1 dependent signaling specificity of coagulation proteases |
| Q36011196 | The outs and the ins of sphingosine-1-phosphate in immunity |
| Q37561507 | The protein C pathway and pathologic processes |
| Q38021497 | The protein C pathway in intestinal barrier function: challenging the hemostasis paradigm |
| Q34060608 | The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications |
| Q38124035 | The role of sphingosine 1-phosphate in immunity and sepsis |
| Q26862336 | The role of sphingosine-1-phosphate in endothelial barrier function |
| Q24599540 | The role of sphingosine-1-phosphate transporter Spns2 in immune system function |
| Q37910045 | The roles of thrombin and protease-activated receptors in inflammation |
| Q33438463 | Thrombin contributes to protective immunity in pneumonia-derived sepsis via fibrin polymerization and platelet-neutrophil interactions |
| Q34316343 | Thrombosis as an intravascular effector of innate immunity |
| Q37357364 | Tissue factor as an initiator of coagulation and inflammation in the lung |
| Q39484501 | Tumor progression locus 2 mediates signal-induced increases in cytoplasmic calcium and cell migration. |
| Q37561489 | Vascular and dendritic cell coagulation signaling in sepsis progression |
| Q40014078 | n-3 Polyunsaturated Fatty Acids Improve Inflammation via Inhibiting Sphingosine Kinase 1 in a Rat Model of Parenteral Nutrition and CLP-Induced Sepsis |
Search more.